Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Anluoqing (envonalkib)
i
Other names:
TQ-B3139, TQ B3139, CT-1139, CT-711
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Shouyao Holdings, Sino Biopharm
Drug class:
ALK inhibitor, ROS1 inhibitor, c-MET inhibitor
Related drugs:
‹
crizotinib (312)
entrectinib (178)
alectinib (104)
lorlatinib (94)
ceritinib (67)
brigatinib (50)
ensartinib (42)
repotrectinib (27)
iruplinalkib (11)
TAE-684 (9)
SAF-189 (7)
APG-2449 (4)
TPX-0131 (4)
TGRX-326 (3)
AZD3463 (2)
OBX02-011 (2)
SY-707 (1)
SY-3505 (1)
NVL-655 (1)
ALK inhibitor (0)
ZG0418 (0)
ASP-3026 (0)
TSR-011 (0)
CEP-37440 (0)
TY-2136b (0)
dirozalkib (0)
taletrectinib (5)
SIM1803-1A (5)
AGX87 (0)
XZP-5955 (0)
NVL-520 (0)
savolitinib (29)
amivantamab-vmjw (25)
tepotinib (24)
capmatinib (23)
TPX-0022 (8)
CKD-702 (6)
GB263T (5)
gumarontinib (5)
ARQ 197 (5)
WXSH0011 (5)
REGN5093 (4)
MGCD265 (4)
AMG 102 (4)
MCLA-129 (3)
ABN401 (3)
BPI-9016 (2)
HS-10241 (2)
AV-299 (2)
GSK1363089 (2)
HQP8361 (2)
S95027 (2)
APL-101 (2)
DO-1 (1)
LY2875358 (1)
GST-HG161 (1)
E7050 (1)
JNJ-38877605 (1)
KRC-108 (1)
RG3638 (1)
SGX523 (1)
SU11274 (1)
AL2846 (0)
AMG 208 (0)
AMG 337 (0)
ARGX-111 (0)
ASKC202 (0)
ASLAN002 (0)
EMB-01 (0)
DO-2 (0)
EMD 1204831 (0)
HLX55 (0)
BMS-794833 (0)
MRX34 (0)
PF-04217903 (0)
PHA665752 (0)
PM1080 (0)
RXDX-106 (0)
amivantamab and hyaluronidase-lpuj (0)
S-49076 (0)
SAIT301 (0)
SAR 125844 (0)
SPH 3348 (0)
TAVO412 (0)
h224G11 (0)
crizotinib (312)
entrectinib (178)
alectinib (104)
lorlatinib (94)
ceritinib (67)
brigatinib (50)
ensartinib (42)
repotrectinib (27)
iruplinalkib (11)
TAE-684 (9)
SAF-189 (7)
APG-2449 (4)
TPX-0131 (4)
TGRX-326 (3)
AZD3463 (2)
OBX02-011 (2)
SY-707 (1)
SY-3505 (1)
NVL-655 (1)
ALK inhibitor (0)
ZG0418 (0)
ASP-3026 (0)
TSR-011 (0)
CEP-37440 (0)
TY-2136b (0)
dirozalkib (0)
taletrectinib (5)
SIM1803-1A (5)
AGX87 (0)
XZP-5955 (0)
NVL-520 (0)
savolitinib (29)
amivantamab-vmjw (25)
tepotinib (24)
capmatinib (23)
TPX-0022 (8)
CKD-702 (6)
GB263T (5)
gumarontinib (5)
ARQ 197 (5)
WXSH0011 (5)
REGN5093 (4)
MGCD265 (4)
AMG 102 (4)
MCLA-129 (3)
ABN401 (3)
BPI-9016 (2)
HS-10241 (2)
AV-299 (2)
GSK1363089 (2)
HQP8361 (2)
S95027 (2)
APL-101 (2)
DO-1 (1)
LY2875358 (1)
GST-HG161 (1)
E7050 (1)
JNJ-38877605 (1)
KRC-108 (1)
RG3638 (1)
SGX523 (1)
SU11274 (1)
AL2846 (0)
AMG 208 (0)
AMG 337 (0)
ARGX-111 (0)
ASKC202 (0)
ASLAN002 (0)
EMB-01 (0)
DO-2 (0)
EMD 1204831 (0)
HLX55 (0)
BMS-794833 (0)
MRX34 (0)
PF-04217903 (0)
PHA665752 (0)
PM1080 (0)
RXDX-106 (0)
amivantamab and hyaluronidase-lpuj (0)
S-49076 (0)
SAIT301 (0)
SAR 125844 (0)
SPH 3348 (0)
TAVO412 (0)
h224G11 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
ALK positive
Non Small Cell Lung Cancer
ALK positive
Non Small Cell Lung Cancer
envonalkib
Sensitive: B - Late Trials
envonalkib
Sensitive
:
B
envonalkib
Sensitive: B - Late Trials
envonalkib
Sensitive
:
B
ROS1 positive
Non Small Cell Lung Cancer
ROS1 positive
Non Small Cell Lung Cancer
envonalkib
Sensitive: C3 – Early Trials
envonalkib
Sensitive
:
C3
envonalkib
Sensitive: C3 – Early Trials
envonalkib
Sensitive
:
C3
ROS1 fusion
Non Small Cell Lung Cancer
ROS1 fusion
Non Small Cell Lung Cancer
envonalkib
Sensitive: C3 – Early Trials
envonalkib
Sensitive
:
C3
envonalkib
Sensitive: C3 – Early Trials
envonalkib
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.